Found: 13
Select item for more details and to access through your institution.
AIEOP‐BFM consensus guidelines 2016 for flow cytometric immunophenotyping of Pediatric acute lymphoblastic leukemia.
- Published in:
- Cytometry. Part B, 2018, v. 94, n. 1, p. 82, doi. 10.1002/cyto.b.21518
- By:
- Publication type:
- Article
Blast cell deficiency of CD11a as a marker of acute megakaryoblastic leukemia and transient myeloproliferative disease in children with and without Down syndrome.
- Published in:
- Cytometry. Part B, 2013, v. 84B, n. 6, p. 370, doi. 10.1002/cyto.b.21082
- By:
- Publication type:
- Article
FCM marker importance for MRD assessment in T‐cell acute lymphoblastic leukemia: An AIEOP‐BFM‐ALL‐FLOW study group report.
- Published in:
- Cytometry. Part A, 2024, v. 105, n. 1, p. 24, doi. 10.1002/cyto.a.24805
- By:
- Publication type:
- Article
Automated Flow Cytometric MRD Assessment in Childhood Acute B‐ Lymphoblastic Leukemia Using Supervised Machine Learning.
- Published in:
- Cytometry. Part A, 2019, v. 95, n. 9, p. 966, doi. 10.1002/cyto.a.23852
- By:
- Publication type:
- Article
Die Vielfalt der Sharing Economy am Beispiel von Online-Plattformen.
- Published in:
- SWS - Rundschau, 2018, v. 58, n. 1, p. 23
- By:
- Publication type:
- Article
Risk factors in DUX4-positive childhood and adolescent B-cell acute lymphoblastic leukemia.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Flow-cytometric minimal residual disease monitoring in blood predicts relapse risk in pediatric B-cell precursor acute lymphoblastic leukemia in trial AIEOP-BFM-ALL 2000.
- Published in:
- 2019
- By:
- Publication type:
- journal article
CD44 deficiency is a consistent finding in childhood Burkitt's lymphoma and leukemia.
- Published in:
- 2007
- By:
- Publication type:
- Letter
Detection and monitoring of normal and leukemic cell populations with hierarchical clustering of flow cytometry data.
- Published in:
- Cytometry. Part A, 2012, v. 81A, n. 1, p. 25, doi. 10.1002/cyto.a.21148
- By:
- Publication type:
- Article
The Use of High-Dose Intravenous l-Ascorbate in Pain Therapy: Current Evidence from the Literature.
- Published in:
- Pain & Therapy, 2024, v. 13, n. 4, p. 767, doi. 10.1007/s40122-024-00622-5
- By:
- Publication type:
- Article
UMAP Based Anomaly Detection for Minimal Residual Disease Quantification within Acute Myeloid Leukemia.
- Published in:
- Cancers, 2022, v. 14, n. 4, p. 898, doi. 10.3390/cancers14040898
- By:
- Publication type:
- Article
An Extensive Quality Control and Quality Assurance (QC/QA) Program Significantly Improves Inter-Laboratory Concordance Rates of Flow-Cytometric Minimal Residual Disease Assessment in Acute Lymphoblastic Leukemia: An I-BFM-FLOW-Network Report.
- Published in:
- Cancers, 2021, v. 13, n. 23, p. 6148, doi. 10.3390/cancers13236148
- By:
- Publication type:
- Article
Expression Patterns of Coagulation Factor XIII Subunit A on Leukemic Lymphoblasts Correlate with Clinical Outcome and Genetic Subtypes in Childhood B-cell Progenitor Acute Lymphoblastic Leukemia.
- Published in:
- Cancers, 2020, v. 12, n. 8, p. 2264, doi. 10.3390/cancers12082264
- By:
- Publication type:
- Article